NRDE2 deficiency impairs homologous recombination repair and sensitizes hepatocellular carcinoma to PARP inhibitors

被引：1

作者：

Wang, Yahui ^{[1
,2
]}

Liu, Xinyi ^{[1
]}

Zuo, Xianbo ^{[3
]}

Wang, Cuiling ^{[1
]}

Zhang, Zheng ^{[1
]}

Zhang, Haitao ^{[1
]}

Zeng, Tao ^{[4
]}

Chen, Shunqi ^{[1
]}

Liu, Mengyu ^{[1
]}

Chen, Hongxia ^{[1
]}

Song, Qingfeng ^{[5
]}

Li, Qi ^{[1
,6
]}

Yang, Chenning ^{[1
]}

Le, Yi ^{[7
]}

Xing, Jinliang ^{[8
]}

Zhang, Hongxin ^{[2
,9
]}

An, Jiaze ^{[10
]}

Jia, Weihua ^{[11
,12
]}

Kang, Longli ^{[13
]}

Zhang, Hongxing ^{[6
]}

Xie, Hui ^{[14
]}

Ye, Jiazhou ^{[15
]}

Wu, Tianzhun ^{[15
]}

He, Fuchu ^{[2
]}

Zhang, Xuejun ^{[16
,17
]}

Li, Yuanfeng ^{[1
]}

Zhou, Gangqiao ^{[1
,18
]}

机构：

[1] Beijing Inst Radiat Med, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Med Prote, Beijing, Peoples R China

[2] Beijing Inst Lifeom, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Med Prote, Beijing, Peoples R China

[3] China Japan Friendship Hosp, Dept Dermatol, Dept Pharm, Beijing, Peoples R China

[4] Chinese Peoples Liberat Army Gen Hosp, Fac Hepatobiliary Pancreat Surg, Med Ctr 1, Beijing, Peoples R China

[5] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China

[6] Univ South China, Sch Med, Dept Neurosci, Hengyang, Hunan, Peoples R China

[7] Chinese Peoples Liberat Army Gen Hosp, Dept Hepatobiliary Surg, Med Ctr 5, Beijing, Peoples R China

[8] Air Force Med Univ, Expt Teaching Ctr Basic Med, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China

[9] Air Force Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian, Shaanxi, Peoples R China

[10] Air Force Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China

[11] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China

[12] Sun Yat Sen Univ, Dept Expt Res, Canc Ctr, Guangzhou, Guangdong, Peoples R China

[13] Xizang Minzu Univ, Sch Med, Key Lab Mol Genet Mech & Intervent Res High Altitu, Key Lab High Altitude Environm & Genes Related Dis, Xianyang, Shaanxi, Peoples R China

[14] Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Oncol, Med Ctr 5, Beijing, Peoples R China

[15] Guangxi Med Univ, Guangxi Liver Canc Diag & Treatment Engn & Technol, Dept Hepatobiliary & Pancreat Surg, Canc Hosp, Nanning, Guangxi, Peoples R China

[16] Anhui Med Univ, Affiliated Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China

[17] Anhui Med Univ, Affiliated Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China

[18] Nanjing Med Univ, Collaborat Innovat Ctr Personalized Canc Med, Ctr Global Hlth, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China

来源：

CELL GENOMICS | 2024年 / 4卷 / 05期

基金：

中国国家自然科学基金;

关键词：

GENOME-WIDE ASSOCIATION; DNA-REPAIR; SUSCEPTIBILITY LOCUS; READ ALIGNMENT; CANCER; EXPRESSION; NBS1; PATHOGENICITY; POLYMORPHISM; FRAMEWORK;

D O I：

10.1016/j.xgen.2024.100550

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

To identify novel susceptibility genes for hepatocellular carcinoma (HCC), we performed a rare -variant association study in Chinese populations consisting of 2,750 cases and 4,153 controls. We identified four HCCassociated genes, including NRDE2 , RANBP17 , RTEL1 , and STEAP3 . Using NRDE2 (index rs199890497 [p.N377I], p = 1.19 3 10 - 9 ) as an exemplary candidate, we demonstrated that it promotes homologous recombination (HR) repair and suppresses HCC. Mechanistically, NRDE2 binds to the subunits of casein kinase 2 (CK2) and facilitates the assembly and activity of the CK2 holoenzyme. This NRDE2-mediated enhancement of CK2 activity increases the phosphorylation of MDC1 and then facilitates the HR repair. These functions are eliminated almost completely by the NRDE2-p.N377I variant, which sensitizes the HCC cells to poly(ADP-ribose) polymerase (PARP) inhibitors, especially when combined with chemotherapy. Collectively, our findings highlight the relevance of the rare variants to genetic susceptibility to HCC, which would be helpful for the precise treatment of this malignancy.

引用

页数：34

共 33 条

[21] Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors
Yuna Suzuki
Wu Wenwen
Tomohiko Ohta
Shin-ichi Hayashi
Breast Cancer, 2022, 29 : 77 - 91
[22] Molecular targeted drugs resistance impairs double-strand break repair and sensitizes ER-positive breast cancer to PARP inhibitors
Suzuki, Yuna
Wu Wenwen
Ohta, Tomohiko
Hayashi, Shin-ichi
BREAST CANCER, 2022, 29 (01) : 77 - 91
[23] Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
Liu, Hangqi
Zhang, Zhiwen
Chen, Longyun
Pang, Junyi
Wu, Huanwen
Liang, Zhiyong
FRONTIERS IN ONCOLOGY, 2022, 11
[24] PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair
Luo, Qingying
Li, Yang
Deng, Jianjun
Zhang, Zunzhen
CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 226 : 12 - 22
[25] GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
Li, Yunzheng
Li, Binghua
Xu, Yanchao
Qian, Liyuan
Xu, Tiancheng
Meng, Gang
Li, Huan
Wang, Ye
Zhang, Laizhu
Jiang, Xiang
Liu, Qi
Xie, Yuanyuan
Cheng, Chunxiao
Sun, Beicheng
Yu, Decai
CANCER RESEARCH, 2022, 82 (18) : 3223 - 3235
[26] Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors
Funato, Kazuyoshi
Otsuka, Motoyuki
Sekiba, Kazuma
Miyakawa, Yu
Seimiya, Takahiro
Shibata, Chikako
Kishikawa, Takahiro
Fujishiro, Mitsuhiro
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 607 : 89 - 95
[27] Cyclin A2 regulates homologous recombination DNA repair and sensitivity to DNA damaging agents and poly(ADP-ribose) polymerase (PARP) inhibitors in human breast cancer cells
Gu, Wei Wei
Lin, Jie
Hong, Xing Yu
ONCOTARGET, 2017, 8 (53) : 90842 - 90851
[28] mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
Mo, Wei
Liu, Qingxin
Lin, Curtis Chun-Jen
Dai, Hui
Peng, Yang
Liang, Yulong
Peng, Guang
Meric-Bernstam, Funda
Mills, Gordon B.
Li, Kaiyi
Lin, Shiaw-Yih
CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1699 - 1712
[29] Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature
Batalini, Felipe
Madison, Russell W.
Sokol, Ethan S.
Jin, Dexter X.
Chen, Kuei-Ting
Decker, Brennan
Pavlick, Dean C.
Frampton, Garrett M.
Wulf, Gerburg M.
Garber, Judy E.
Oxnard, Geoffrey
Schrock, Alexa B.
Tung, Nadine M.
JCO PRECISION ONCOLOGY, 2023, 7
[30] PPIP5K2 promotes colorectal carcinoma pathogenesis through facilitating DNA homologous recombination repair
Cao, Chen-Hui
Ling, Han
Han, Kai
Lu, Xiao-Peng
Cai, Mu-Yan
Cao, Jing-Hua
Zhou, Jie
Xiang, Zhi-Cheng
Chen, Jie-Wei
Li, Si
Lin, Jin-Long
Duan, Jin-Ling
Luo, Jie
Fang, Yu-Jing
Pan, Zhi-Zhong
Liang, Li
Wang, Feng
Xie, Dan
Wang, Feng-Wei
ONCOGENE, 2021, 40 (49) : 6680 - 6691

← 1 2 3 4 →